Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Leonard

Showing results (621-630 of 669) with videos related to

Pageof 67
Sort By:
American Journal of Hematology|June 2, 2005
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemiaSteven D Gore, B Douglas Smith, Ivana Gojo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH studyMeena Thayu, Mary B Leonard, Jeffrey S Hyams, et al.
The Journal of Infectious Diseases|March 11, 2015
Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected WomenVincent Lo Re, Kenneth Lynn, Emily R Stumm, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2015
The Pathologist Workforce in the United States: II. An Interactive Modeling Tool for Analyzing Future Qualitative and Quantitative Staffing Demands for ServicesStanley J Robboy, Saurabh Gupta, James M Crawford, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
Fibroblast growth factor 23 and Inflammation in CKDJair Munoz Mendoza, Tamara Isakova, Ana C Ricardo, et al.
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
Therapeutic Advances in Respiratory Disease|April 19, 2023
Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosisTodd L Astor, Hilary J Goldberg, Laurie D Snyder, et al.
Annals of the American Thoracic Society|November 12, 2024
Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) RegistryCoralynn Sack, Daniel M Wojdyla, Maeve G MacMurdo, et al.
Journal of the American Society of Nephrology : JASN|July 26, 2011
Discriminants of prevalent fractures in chronic kidney diseaseThomas L Nickolas, Serge Cremers, Amy Zhang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2014
Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC studyF Perry Wilson, Dawei Xie, Amanda H Anderson, et al.
Pageof 67

Showing results (621-630 of 669) with videos related to

Sort By:
Pageof 67
American Journal of Hematology|June 2, 2005
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemiaSteven D Gore, B Douglas Smith, Ivana Gojo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 17, 2008
Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH studyMeena Thayu, Mary B Leonard, Jeffrey S Hyams, et al.
The Journal of Infectious Diseases|March 11, 2015
Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected WomenVincent Lo Re, Kenneth Lynn, Emily R Stumm, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2015
The Pathologist Workforce in the United States: II. An Interactive Modeling Tool for Analyzing Future Qualitative and Quantitative Staffing Demands for ServicesStanley J Robboy, Saurabh Gupta, James M Crawford, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 5, 2012
Fibroblast growth factor 23 and Inflammation in CKDJair Munoz Mendoza, Tamara Isakova, Ana C Ricardo, et al.
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
Therapeutic Advances in Respiratory Disease|April 19, 2023
Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosisTodd L Astor, Hilary J Goldberg, Laurie D Snyder, et al.
Annals of the American Thoracic Society|November 12, 2024
Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) RegistryCoralynn Sack, Daniel M Wojdyla, Maeve G MacMurdo, et al.
Journal of the American Society of Nephrology : JASN|July 26, 2011
Discriminants of prevalent fractures in chronic kidney diseaseThomas L Nickolas, Serge Cremers, Amy Zhang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2014
Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC studyF Perry Wilson, Dawei Xie, Amanda H Anderson, et al.
Pageof 67